FDA Newsroom

 

 

 

 

 

 

Latest Press Announcements

---

 

July 2025

• July 18, 2025 - FDA Requests Sarepta Therapeutics Suspend Distribution of Elevidys and Places Clinical Trials on Hold for Multiple Gene Therapy Products Following 3 Deaths
• July 16, 2025 - FDA to Revoke 52 Obsolete Standards of Identity for Food Products
• July 15, 2025 - FDA Issues Warning Letters to Firms Marketing Products Containing 7-Hydroxymitragynine
• July 14, 2025 - FDA Approves Gardenia (Genipin) Blue Color Additive While Encouraging Faster Phase-Out of FD&C Red No. 3
• July 10, 2025 - A Statement from FDA Commissioner Marty Makary, M.D., M.P.H: 100 Days of Embracing Gold-Standard Science, Transparency and Common Sense
• July 10, 2025 - FDA Embraces Radical Transparency by Publishing Complete Response Letters
• July 9, 2025 - FDA Encourages Industry Leaders to Streamline, Enhance Product Recall Communications to Safeguard Foods for Infants and Children

June 2025

• June 27, 2025 - FDA Eliminates Risk Evaluation and Mitigation Strategies (REMS) for Autologous Chimeric Antigen Receptor CAR T cell Immunotherapies
• June 18, 2025 - FDA Halts New Clinical Trials That Export Americans’ Cells to Foreign Labs in Hostile Countries for Genetic Engineering
• June 17, 2025 - FDA to Issue New Commissioner’s National Priority Vouchers to Companies Supporting U.S. National Interests

Pagination

• First page « First
• Previous page ‹‹
• …
• Page 4
• Page 5
• Page 6
• Page 7
• Current page 8
• Page 9
• Page 10
• Page 11
• Page 12
• …
• Next page ››
• Last page Last »